Overview

Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Glutamine may help prevent mucositis, or mouth sores, in patients receiving chemotherapy for sarcoma. It is not yet known whether glutamine is more effective than a placebo in preventing mucositis in patients receiving chemotherapy for sarcoma. PURPOSE: This randomized clinical trial is studying glutamine to see how well it works compared to a placebo in preventing oral mucositis in patients receiving chemotherapy for sarcoma.
Phase:
N/A
Details
Lead Sponsor:
Children's Oncology Group
Collaborator:
National Cancer Institute (NCI)